Your browser doesn't support javascript.
loading
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
Raymond, Eric; Kulke, Matthew H; Qin, Shukui; Yu, Xianjun; Schenker, Michael; Cubillo, Antonio; Lou, Wenhui; Tomasek, Jiri; Thiis-Evensen, Espen; Xu, Jian-Ming; Croitoru, Adina E; Khasraw, Mustafa; Sedlackova, Eva; Borbath, Ivan; Ruff, Paul; Oberstein, Paul E; Ito, Tetsuhide; Jia, Liqun; Hammel, Pascal; Shen, Lin; Shrikhande, Shailesh V; Shen, Yali; Sufliarsky, Jozef; Khan, Gazala N; Morizane, Chigusa; Galdy, Salvatore; Khosravan, Reza; Fernandez, Kathrine C; Rosbrook, Brad; Fazio, Nicola.
Afiliación
  • Raymond E; Department of Medical Oncology, Paris Saint-Joseph Hospital Group, Paris, France.
  • Kulke MH; Program in Neuroendocrine and Carcinoid Tumors, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Qin S; PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China.
  • Yu X; Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Schenker M; Centrul de Oncologie Sf. Nectarie, Oncologie Medicala, Craiova, Romania.
  • Cubillo A; Hospital Universitario Madrid Sanchinarro, Centro Integral Oncológico Clara Campal, Madrid, Spain.
  • Lou W; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tomasek J; Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic.
  • Thiis-Evensen E; Department of Gastroenterology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Xu JM; No. 307 Hospital, Academy of Military Medical Sciences, Beijing, China.
  • Croitoru AE; Department of Medical Oncology, Fundeni Clinical Institute, Bucharest, Romania.
  • Khasraw M; Andrew Love Cancer Center, Geelong Hospital, Victoria, Victoria, Australia.
  • Sedlackova E; Vseobecné Fakultní Nemocnice v Praze Onkologická Klinika, Prague, Czech Republic.
  • Borbath I; Hepato-Gastroenterology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Ruff P; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Oberstein PE; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York, USA.
  • Ito T; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Jia L; China-Japan Friendship Hospital, Beijing, China.
  • Hammel P; Service d'Oncologie Digestive, Hôpital Beaujon, Clichy, France.
  • Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Shrikhande SV; GI and HPB Surgical Oncology, Tata Memorial Hospital, Mumbai, India.
  • Shen Y; West China Hospital of Sichuan University, Chengdu, China.
  • Sufliarsky J; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Khan GN; Henry Ford Health System, Detroit, Michigan, USA.
  • Morizane C; National Cancer Center, Tokyo, Japan.
  • Galdy S; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, Milan, Italy.
  • Khosravan R; Pfizer Oncology, Pfizer Inc., San Diego, California, USA.
  • Fernandez KC; Pfizer Oncology, Pfizer Inc., Cambridge, Massachusetts, USA.
  • Rosbrook B; Pfizer Oncology, Pfizer Inc., San Diego, California, USA.
  • Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, Milan, Italynicola.fazio@ieo.it.
Neuroendocrinology ; 107(3): 237-245, 2018.
Article en En | MEDLINE | ID: mdl-29991024
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos / Sunitinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroendocrinology Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tumores Neuroendocrinos / Sunitinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroendocrinology Año: 2018 Tipo del documento: Article País de afiliación: Francia